In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Sanjiv Bhasin of IIFL shared his reading and outlook on the market and also gave recommendations on various stocks.

Hold Sun Pharmaceutical; target of Rs 680: Axis Direct

Axis Direct recommended hold rating on Sun Pharmaceutical with a target price of Rs 680 in its research report dated February 21, 2017.

Buy Sun Pharma; target of Rs 810: Centrum

Centrum is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 810 in its research report dated February 15, 2017.

Buy Sun Pharma; target of Rs 850: HDFC Securities

HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated February 15, 2017.

Buy Sun Pharmaceutical; target of Rs 832: Khambatta Securities

Khambatta Securities is bullish on Sun Pharmaceutical has recommended buy rating on the stock with a target price of Rs 832 in its research report dated February 15, 2017.

Buy Sun Pharmaceuticals; target of Rs 860: Edelweiss

Edelweiss is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 860 in its research report dated February 14, 2017.

Here are SP Tulsian's stock ideas

In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

Nifty on Cloud Nine! 9 stocks with a high margin of safety

With Nifty a whisker away from its lifetime high and valuation touching 21X FY17P and 18X FY18P earnings, the Street looks cautious. Is it time to take money off the table?

Buy Sun Pharma; target of Rs 875: Religare

Religare is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 875 in its research report dated December 13, 2016.

Buy Sun Pharmaceuticals; target of Rs 875: Religare

Religare is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 875 in its research report dated November 24, 2016.

Buy Sun Pharma; target of Rs 925: Motilal Oswal

Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 925 in its research report dated November 23, 2016.

Accumulate Sun Pharma; target of Rs 873: Prabhudas Lilladher

Prabhudas Lilladher has recommended accumulate rating on Sun Pharma with a target price of Rs 873 in its research report dated November 10, 2016.

Buy Sun Pharmaceutical Industries; target of Rs 940: KR Choksey

KR Choksey is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 940 in its research report dated November 11, 2016.

Hold Sun Pharmaceuticals; target of Rs 875: Religare

Religare recommended hold rating on Sun Pharmaceuticals with a target price of Rs 875 in its research report dated August 16, 2016.

Hold Sun Pharmaceuticals; target of Rs 790: Axis Direct

Axis Direct has recommended hold rating on Sun Pharmaceuticals Industries with a target price of Rs 790 in its research report dated August 16, 2016.

Buy Sun Pharma; target of Rs 940: KR Choksey

KR Choksey is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 940 in its research report dated August 16, 2016.

Buy Sun Pharma; target of Rs 910: Edelweiss

Edelweiss is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 910 in its research report dated August 12, 2016.

Buy Sun Pharma; target of Rs 823: Geojit BNP Paribas

Geojit BNP Paribas is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 823 in its research report dated June 06, 2016.

Buy Sun Pharma; target of Rs 970: GeoJit BNP Paribas

GeoJit BNP Paribas is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 970 in its research report dated April 25, 2016.

Buy Sun Pharma; target of Rs 920: Edelweiss

Edelweiss is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 920 in its research report dated April 11, 2016.

Buy Sun Pharma;target of Rs 940: Religare

Religare is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 940 in its research report dated February 20, 2016.

Buy Sun Pharma;target of Rs 980: Khambatta Securities

Khambatta Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 980 in its research report dated February 15, 2016.

Buy Sun Pharma;target of Rs 971: KRChoksey

KRChoksey is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 971 in its research report dated February 15, 2016.

Buy Sun Pharma;target of Rs 971: KRChoksey

KRChoksey is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 971 in its research report dated February 15, 2016.

Buy Sun Pharma; target of Rs 975:Motilal Oswal

Motilal Oswal is bullish on Sun Pharma and has recommended buy rating on the stock with a target price of Rs 975 in its research report dated January 13, 2016.